| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.540 | 14.803 | 14.359 | 2.121 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 16.540 | 14.803 | 14.365 | 2.121 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 13.425 | 10.326 | 12.542 | 5.143 | 0 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 3.115 | 4.476 | 1.823 | -3.022 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 2.618 | 4.180 | 1.680 | -3.044 | 0 | 0 | 0 | 0 | 0 | - |
| Employees | 2 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Gamamedical Expert Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.261 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 10.867 | 16.161 | 20.794 | 11.586 | 11.362 | 11.146 | 10.899 | 10.933 | 10.900 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 854 | 2.067 | 206 | 0 | 0 | 0 | 0 | 0 | 10.900 | - |
| Cash | 10.014 | 14.094 | 20.588 | 11.586 | 11.362 | 11.146 | 10.899 | 10.933 | 0 | - |
| Shareholders Funds | 9.366 | 13.451 | 14.903 | 11.586 | 11.362 | 11.146 | 10.899 | 10.933 | 10.900 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 2.763 | 2.711 | 5.891 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Gamamedical Expert Srl